More J&J Vaccines Made by Emergent Are Released by FDA (1)

Another batch of the main ingredient for Johnson & Johnson’s coronavirus vaccine made at a troubled Emergent BioSolutions Inc. facility in Baltimore has been released by the Food and Drug Administration.

The FDA said in a letter Tuesday to J&J that it is waiving manufacturing standards since Emergent was in violation at the time the drug substance was produced. The agency also said the clearance doesn’t mean the Emergent plant has the green light to again make the vaccine ingredient.

The clearance will allow 10 million doses of the vaccine that have already been placed into vials to be ...